Novartis Investigative Site — Taipei

Public research footprint of Novartis Investigative Site, compiled from the ClinicalTrials.gov public registry.

277

Registered studies

Active

Recruiting now

178

Completed

Stopped or withdrawn

Most-studied conditions

Primary Prevention of Atherosclerotic Cardiovascular Disease · Advanced NRAS/BRAFT wt Cutaneous Melanoma · Advanced CCNE1-amplified Solid Tumors · Metastatic Castration-resistant Prostate Cancer

Recently updated registry entries

NCT05939414 — An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… (Recruiting)
NCT07288359 — Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients… (Recruiting)
NCT04557462 — A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Novartis Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.